Epassi Group Expands into Southern Europe with the Acquisition of VIP District
17.6.2025 08:00:00 CEST | Business Wire | Press Release
Epassi Group’s acquisition of VIP District (www.vipdistrict.com) marks a major milestone in Epassi’s pan-European growth strategy and follows Epassi’s recent acquisition of Zest in the UK, which expanded the Group’s UK footprint and enhanced its overall employee benefits software offering. With VIP District now part of the Epassi family, the Group significantly expands its footprint into Spain and Portugal, while strengthening its existing presence in Italy, Germany, and the Netherlands.
Founded in 2010, VIP District supports over 3,000 companies with its digital platform, offering exclusive employee rewards and incentives, recognition tools, and engagement solutions. The company has become a leader in Southern Europe, helping employers boost retention, satisfaction, and wellbeing.
“This partnership accelerates our ambition to build the leading European tech platform for employee benefits and wellbeing,” said Pekka Rantala, CEO of Epassi Group. “VIP District brings a strong market position, an excellent team, and a shared passion for innovation and employee experience. Together, we are strengthening our reward services proposition across Europe, delivering even more value to our clients and their employees.”
The combination unites two highly complementary platforms – Epassi’s multi-benefit platform and VIP District’s engagement and reward services – creating a unique, scalable offering that enables employers to engage, recognize, and reward their employees with greater impact and flexibility.
“VIP District has always focused on innovation and strategic, sustainable growth,” said Jesús Alonso, CEO of VIP District. “Today’s partnership with Epassi is the latest step in our mission to become the preferred all in one employee engagement platform with benefits, employee discounts, internal communication, recognition and rewards across Europe. By combining forces, we can deliver even more value to our customers—helping them attract, motivate, and retain talent in a dynamic market.”
This acquisition further solidifies Epassi’s position as a European leader in the employee benefits ecosystem, now serving over 45,000 employers and more than 29 million users across the Nordics, UK, Ireland, Germany, the Netherlands, Italy, Spain, Portugal, and France.
About Epassi
Founded in 2007, Epassi is a leading provider of employee benefits technology operating across Finland, Sweden, Germany, the Netherlands, Italy, the UK and Ireland. Epassi’s innovative, mobile and digital first platform serves around 46,000 employers and their more than 29 million employees, partnering with over 97,000 service providers across its benefits ecosystem.
Epassi has been recognized by the Financial Times as one of the fastest growing companies in Europe in 2022, 2023, 2024, and 2025. Epassi was ranked 32nd on “Europe’s Long-term Growth Champions 2025” list.
Epassi – Boosting everyday well-being.
About VIP District
Founded in 2010, VIP District provides digital engagement solutions that help companies enhance employee experience through rewards, recognition, internal communication and exclusive discounts. Headquartered in Madrid and offices in 8 locations, the company serves over 3,000 employers and 7 million users across Europe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250616658244/en/
Contacts
Press Contacts
Seven Consultancy: epassi@seven-consultancy.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press Release
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press Release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press Release
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press Release
Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press Release
Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom